— Know what they know.
Not Investment Advice

VNDA NASDAQ

Vanda Pharmaceuticals Inc.
1W: -3.0% 1M: -9.2% 3M: +7.6% YTD: -24.9% 1Y: +39.6% 3Y: +0.8% 5Y: -66.8%
$6.19
-0.02 (-0.32%)
After Hours: $6.32 (+0.13, +2.10%)
Weekly Expected Move ±9.2%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $372.2M mcap · 54M float · 4.51% daily turnover · Short 59% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.3 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -166.8%  ·  5Y Avg: -34.2%
Cost Advantage ★
50
Intangibles
45
Switching Cost
41
Network Effect
43
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. VNDA shows a Weak competitive edge (41.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -166.8% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$21
Low
$21
Avg Target
$21
High
Based on 1 analyst since May 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 13Hold: 5Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$22.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-11 H.C. Wainwright $24 $21 -3 +234.4% $6.28
2026-02-23 H.C. Wainwright $22 $24 +2 +182.9% $8.48
2026-01-05 H.C. Wainwright Initiated $22 +166.7% $8.25
2025-12-31 Jefferies Initiated $8 +6.7% $7.03
2025-11-05 B.Riley Financial Madison El-Saadi Initiated $11 +152.9% $4.35
2024-07-11 Cantor Fitzgerald Charles Duncan Initiated $11 +111.1% $5.21

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. VNDA receives an overall rating of C. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-02-17 D+ C
2026-02-12 C D+
2026-02-12 B- C
2026-02-11 B B-
2026-02-11 B- B
2026-02-09 B B-
2026-02-06 B- B
2026-01-26 B B-
2026-01-16 B- B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

21 Grade D
Profitability
20
Balance Sheet
86
Earnings Quality
18
Growth
39
Value
40
Momentum
40
Safety
15
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. VNDA scores highest in Balance Sheet (86/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.28
Distress Zone
Piotroski F-Score
2/9
Beneish M-Score
-3.63
Unlikely Manipulator
Ohlson O-Score
-4.79
Bankruptcy prob: 0.8%
Low Risk
Credit Rating
BB+
Score: 47.6/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.53x
Accruals: -19.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. VNDA scores 0.28, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. VNDA scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. VNDA's score of -3.63 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. VNDA's implied 0.8% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. VNDA receives an estimated rating of BB+ (score: 47.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.53x
PEG
0.01x
P/S
1.70x
P/B
1.30x
P/FCF
-3.23x
P/OCF
EV/EBITDA
-1.11x
EV/Revenue
0.73x
EV/EBIT
-1.02x
EV/FCF
-1.25x
Earnings Yield
-58.30%
FCF Yield
-30.98%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. VNDA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.600
NI / EBT
×
Interest Burden
0.955
EBT / EBIT
×
EBIT Margin
-0.720
EBIT / Rev
×
Asset Turnover
0.380
Rev / Assets
×
Equity Multiplier
1.323
Assets / Equity
=
ROE
-55.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. VNDA's ROE of -55.3% is driven by Asset Turnover (0.380), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.60 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.19
Median 1Y
$4.51
5th Pctile
$1.76
95th Pctile
$11.59
Ann. Volatility
57.8%
Analyst Target
$22.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Mihael H. Polymeropoulos,
M.D. President, Chief Executive Officer and Chairman of the Board
$965,655 $2,007,000 $3,851,468
Joakim Wijkstrom President,
e President, Chief Marketing Officer
$579,600 $557,500 $1,457,528
Timothy Williams President,
e President, General Counsel and Secretary
$559,935 $557,500 $1,444,969
Kevin Moran President,
e President, Chief Financial Officer and Treasurer
$559,935 $557,500 $1,439,660
Gunther Birznieks President,
e President, Business Development
$559,935 $557,500 $1,415,471

CEO Pay Ratio

6:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,851,468
Avg Employee Cost (SGA/emp): $646,606
Employees: 368

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
368
0.0% YoY
Revenue / Employee
$587,242
Rev: $216,105,000
Profit / Employee
$-599,114
NI: $-220,474,000
SGA / Employee
$646,606
Avg labor cost proxy
R&D / Employee
$296,932
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 7.5% 7.9% 6.9% 3.8% 2.3% 1.4% 1.2% 3.1% 2.9% 2.3% 0.5% -0.9% -2.0% -3.1% -3.5% -8.2% -12.4% -15.5% -50.9% -55.3% -55.34%
ROA 6.4% 6.7% 5.9% 3.2% 2.0% 1.2% 1.0% 2.6% 2.4% 1.9% 0.4% -0.8% -1.7% -2.6% -2.9% -6.8% -10.3% -12.9% -38.5% -41.8% -41.84%
ROIC 31.6% 34.0% 39.1% 21.2% 12.8% 6.2% 4.9% 14.6% 8.7% -0.2% -3.3% -12.0% -15.4% -17.8% -18.2% -34.1% -46.8% -55.9% -1.6% -1.7% -1.67%
ROCE 8.9% 9.5% 8.1% 4.7% 3.0% 1.7% 1.2% 3.7% 2.4% 0.6% -1.9% -4.5% -5.8% -6.7% -7.3% -11.4% -15.9% -19.5% -40.3% -45.6% -45.59%
Gross Margin 90.3% 90.3% 90.8% 90.6% 90.6% 90.3% 90.3% 92.4% 92.4% 92.1% 92.4% 88.5% 91.1% 94.6% 95.1% 93.0% 91.5% 94.7% 93.3% 90.0% 90.05%
Operating Margin 18.2% 15.4% 12.7% -12.7% 5.4% 6.0% 10.3% 3.2% -6.2% -15.4% -15.7% -19.5% -20.1% -23.1% -19.3% -89.0% -73.2% -55.6% -70.5% -97.1% -97.11%
Net Margin 14.2% 11.1% 10.4% -10.7% 4.0% 5.0% 10.6% 5.2% 3.3% 0.4% -5.3% -8.7% -9.0% -11.2% -9.2% -58.9% -51.7% -40.1% -2.5% -93.9% -93.91%
EBITDA Margin 19.3% 16.4% 13.7% -11.6% 7.0% 7.0% 11.3% 9.9% -4.9% -14.0% -13.1% -14.8% -16.2% -19.0% -15.6% -62.2% -62.5% -52.0% -60.3% -90.3% -90.29%
FCF Margin 21.4% 20.7% 23.7% 22.0% 17.3% 18.9% 12.3% 23.0% 16.9% 12.1% 6.4% -6.6% -3.0% -9.5% -8.2% -28.5% -32.4% -39.1% -51.1% -58.5% -58.45%
OCF Margin 22.0% 21.2% 23.9% 22.2% 17.4% 19.1% 12.6% 23.3% 17.1% 12.2% 6.6% -6.4% -2.8% -9.3% -7.9% -28.0% -31.8% -38.6% -50.6% -58.1% -58.09%
ROE 3Y Avg snapshot only -27.44%
ROE 5Y Avg snapshot only -15.14%
ROA 3Y Avg snapshot only -18.83%
ROIC 3Y Avg snapshot only -60.09%
ROIC Economic snapshot only -37.77%
Cash ROA snapshot only -25.87%
Cash ROIC snapshot only -1.67%
CROIC snapshot only -1.68%
NOPAT Margin snapshot only -58.17%
Pretax Margin snapshot only -68.74%
R&D / Revenue snapshot only 46.83%
SGA / Revenue snapshot only 1.18%
SBC / Revenue snapshot only 2.99%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 37.73 28.53 27.09 35.11 56.34 86.70 67.35 24.42 25.44 21.14 96.77 -48.56 -30.10 -16.67 -14.78 -6.07 -4.16 -3.49 -2.36 -1.72 -1.528
P/S Ratio 4.73 3.64 3.34 2.38 2.36 2.18 1.66 1.52 1.59 1.17 1.26 1.34 1.81 1.43 1.41 1.33 1.37 1.39 2.41 1.89 1.700
P/B Ratio 2.70 2.16 1.78 1.26 1.23 1.11 0.80 0.74 0.72 0.47 0.45 0.44 0.60 0.50 0.52 0.50 0.52 0.55 1.59 1.26 1.303
P/FCF 22.16 17.61 14.10 10.83 13.66 11.58 13.50 6.60 9.40 9.74 19.55 -20.17 -59.45 -15.01 -17.19 -4.68 -4.22 -3.54 -4.72 -3.23 -3.228
P/OCF 21.52 17.18 13.98 10.74 13.54 11.45 13.21 6.52 9.28 9.59 18.97
EV/EBITDA 19.67 13.18 10.61 7.93 10.82 12.45 -3.52 -2.92 -4.84 -35.61 18.34 6.86 1.88 3.50 2.55 1.65 1.03 0.67 -2.11 -1.11 -1.114
EV/Revenue 3.36 2.32 1.78 0.80 0.76 0.55 -0.13 -0.26 -0.32 -0.98 -0.71 -0.80 -0.27 -0.55 -0.42 -0.47 -0.41 -0.32 1.25 0.73 0.733
EV/EBIT 21.02 14.03 11.32 8.86 12.77 16.43 -4.97 -3.32 -5.80 -62.79 13.05 5.62 1.54 2.82 2.04 1.47 0.95 0.63 -1.95 -1.02 -1.018
EV/FCF 15.75 11.23 7.50 3.66 4.39 2.93 -1.06 -1.12 -1.90 -8.10 -10.96 12.02 9.02 5.80 5.11 1.63 1.27 0.83 -2.45 -1.25 -1.254
Earnings Yield 2.7% 3.5% 3.7% 2.8% 1.8% 1.2% 1.5% 4.1% 3.9% 4.7% 1.0% -2.1% -3.3% -6.0% -6.8% -16.5% -24.0% -28.7% -42.3% -58.3% -58.30%
FCF Yield 4.5% 5.7% 7.1% 9.2% 7.3% 8.6% 7.4% 15.2% 10.6% 10.3% 5.1% -5.0% -1.7% -6.7% -5.8% -21.4% -23.7% -28.2% -21.2% -31.0% -30.98%
PEG Ratio snapshot only 0.013
Price/Tangible Book snapshot only 1.956
EV/Gross Profit snapshot only 0.793
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.21 6.21 6.43 6.43 6.43 6.43 5.68 5.68 5.68 5.68 4.94 4.94 4.94 4.94 4.39 4.39 4.39 4.39 2.39 2.39 2.392
Quick Ratio 6.19 6.19 6.41 6.41 6.41 6.41 5.67 5.67 5.67 5.67 4.92 4.92 4.92 4.92 4.37 4.37 4.37 4.37 2.38 2.38 2.379
Debt/Equity 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.04 0.04 0.039
Net Debt/Equity -0.78 -0.78 -0.83 -0.83 -0.83 -0.83 -0.86 -0.86 -0.86 -0.86 -0.70 -0.70 -0.70 -0.70 -0.67 -0.67 -0.67 -0.67 -0.77 -0.77 -0.768
Debt/Assets 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.03 0.03 0.026
Debt/EBITDA 0.31 0.29 0.27 0.46 0.67 1.08 1.19 0.49 0.70 1.92 -1.27 -0.46 -0.35 -0.31 -0.38 -0.22 -0.15 -0.12 -0.10 -0.09 -0.088
Net Debt/EBITDA -8.01 -7.49 -9.34 -15.58 -22.87 -36.75 -48.53 -20.20 -28.82 -78.44 51.07 18.37 14.28 12.56 11.14 6.40 4.45 3.57 1.97 1.75 1.753
Interest Coverage
Equity Multiplier 1.18 1.18 1.18 1.18 1.18 1.18 1.20 1.20 1.20 1.20 1.19 1.19 1.19 1.19 1.22 1.22 1.22 1.22 1.49 1.49 1.494
Cash Ratio snapshot only 1.818
Cash to Debt snapshot only 20.904
FCF to Debt snapshot only -10.085
Defensive Interval snapshot only 321.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.51 0.53 0.48 0.47 0.47 0.46 0.41 0.42 0.39 0.35 0.30 0.28 0.28 0.30 0.30 0.31 0.31 0.33 0.38 0.38 0.380
Inventory Turnover 20.58 21.33 22.24 21.92 21.48 21.07 21.89 21.08 18.78 15.84 11.60 12.14 12.91 12.51 9.79 8.53 8.53 8.79 8.27 9.18 9.178
Receivables Turnover 9.17 9.51 8.60 8.52 8.41 8.25 7.71 7.78 7.23 6.42 5.69 5.25 5.38 5.64 4.89 4.96 5.01 5.22 4.25 4.28 4.284
Payables Turnover 7.16 7.42 25.97 25.60 25.08 24.60 3.57 3.44 3.06 2.58 1.49 1.56 1.66 1.61 2.83 2.47 2.47 2.55 3.51 3.89 3.892
DSO 40 38 42 43 43 44 47 47 51 57 64 70 68 65 75 74 73 70 86 85 85.2 days
DIO 18 17 16 17 17 17 17 17 19 23 31 30 28 29 37 43 43 42 44 40 39.8 days
DPO 51 49 14 14 15 15 102 106 119 141 245 234 220 227 129 148 148 143 104 94 93.8 days
Cash Conversion Cycle 7 6 45 45 46 47 -38 -42 -49 -62 -149 -134 -124 -133 -17 -31 -32 -32 26 31 31.2 days
Fixed Asset Turnover snapshot only 16.115
Operating Cycle snapshot only 125.0 days
Cash Velocity snapshot only 0.825
Capital Intensity snapshot only 2.245
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 7.4% 11.1% 8.3% 5.3% 1.6% -3.9% -5.3% -3.6% -9.3% -17.9% -24.3% -30.8% -23.6% -9.9% 3.2% 13.4% 11.8% 11.1% 8.7% 8.2% 8.16%
Net Income -71.5% 77.0% 42.1% -42.6% -66.1% -81.1% -81.1% -11.7% 35.6% 81.3% -60.0% -1.3% -1.7% -2.4% -8.5% -8.1% -5.1% -4.1% -10.7% -4.4% -4.41%
EPS -72.4% 71.3% 40.3% -42.2% -66.1% -81.0% -81.1% -13.7% 33.9% 79.3% -60.3% -1.3% -1.7% -2.4% -8.4% -7.9% -5.0% -4.1% -10.5% -4.3% -4.33%
FCF 45.6% 34.2% 27.4% -2.9% -17.9% -12.4% -50.8% 0.9% -11.1% -47.4% -60.3% -1.2% -1.1% -1.7% -2.3% -3.9% -10.9% -3.6% -5.8% -1.2% -1.22%
EBITDA 55.4% 97.8% 47.2% -34.2% -58.4% -75.8% -79.1% -16.4% -14.0% -49.2% -1.8% -1.9% -2.7% -6.2% -3.4% -1.7% -2.1% -2.4% -2.9% -1.5% -1.53%
Op. Income 70.1% 1.1% 54.8% -35.9% -62.7% -81.0% -85.0% -33.8% -36.6% -1.0% -3.2% -2.6% -4.4% -162.6% -1.9% -2.0% -2.2% -2.3% -2.8% -1.1% -1.11%
OCF Growth snapshot only -1.24%
Asset Growth snapshot only -25.49%
Equity Growth snapshot only -39.25%
Debt Growth snapshot only 2.12%
Shares Change snapshot only 1.59%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 13.6% 13.3% 11.6% 10.5% 7.9% 5.6% 3.8% 2.6% -0.3% -4.3% -8.1% -11.1% -11.0% -10.7% -9.6% -8.9% -8.2% -6.3% -5.3% -5.3% -5.33%
Revenue 5Y 14.8% 14.0% 13.0% 12.1% 11.0% 10.2% 9.0% 8.4% 6.2% 2.8% -0.0% -2.1% -2.7% -2.7% -2.6% -3.2% -3.3% -2.6% -2.7% -2.9% -2.94%
EPS 3Y 1.9% 36.2% 8.3% -7.6% -28.1% -62.9% -62.6% -49.2% -50.0% -16.5% -52.7%
EPS 5Y 61.1% -3.0% -37.5%
Net Income 3Y 1.9% 38.1% 9.6% -5.7% -27.2% -62.4% -62.1% -48.5% -49.2% -15.3% -52.4%
Net Income 5Y 63.2% -2.0% -37.0%
EBITDA 3Y 1.7% 52.2% 22.1% 10.8% -12.5% -30.1% -31.0% -9.9% -17.8% -37.6%
EBITDA 5Y 47.3% -15.4%
Gross Profit 3Y 14.1% 13.8% 12.1% 11.0% 8.4% 6.1% 4.3% 3.1% 0.1% -3.8% -7.5% -10.8% -10.8% -10.3% -8.9% -7.9% -7.2% -5.3% -4.4% -4.8% -4.79%
Gross Profit 5Y 17.5% 16.3% 14.9% 13.6% 11.9% 10.7% 9.3% 8.8% 6.7% 3.4% 0.6% -1.6% -2.4% -2.2% -2.0% -2.4% -2.6% -1.9% -2.2% -2.5% -2.51%
Op. Income 3Y 61.5% 24.7% 12.0% -13.0% -33.0% -34.8% -13.6% -26.2%
Op. Income 5Y
FCF 3Y 1.4% 67.9% -5.2% -1.2% -11.3% 19.8% 2.0% -14.8% -37.1%
FCF 5Y 74.1% 21.9%
OCF 3Y 69.6% 46.3% 28.9% 15.8% -5.5% -1.5% -11.4% 19.1% 1.6% -15.0% -37.2%
OCF 5Y 64.2% 28.5% 7.4% -15.7%
Assets 3Y 37.5% 37.5% 21.4% 21.4% 21.4% 21.4% 9.4% 9.4% 9.4% 9.4% 6.7% 6.7% 6.7% 6.7% 3.4% 3.4% 3.4% 3.4% -8.3% -8.3% -8.31%
Assets 5Y 20.1% 20.1% 23.1% 23.1% 23.1% 23.1% 25.3% 25.3% 25.3% 25.3% 14.3% 14.3% 14.3% 14.3% 6.3% 6.3% 6.3% 6.3% -1.7% -1.7% -1.73%
Equity 3Y 51.1% 51.1% 22.4% 22.4% 22.4% 22.4% 8.7% 8.7% 8.7% 8.7% 6.3% 6.3% 6.3% 6.3% 2.2% 2.2% 2.2% 2.2% -14.7% -14.7% -14.70%
Book Value 3Y 48.4% 49.0% 20.9% 19.9% 20.8% 20.6% 7.2% 7.0% 7.1% 7.1% 5.7% 5.6% 5.5% 5.6% 1.5% 0.7% 0.9% 1.1% -15.6% -15.7% -15.70%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.99 1.00 0.99 0.97 0.96 0.90 0.85 0.82 0.59 0.20 0.02 0.00 0.04 0.17 0.26 0.35 0.47 0.50 0.45 0.36 0.365
Earnings Stability 0.60 0.29 0.26 0.17 0.12 0.01 0.00 0.00 0.01 0.17 0.31 0.32 0.41 0.68 0.75 0.84 0.87 0.70 0.60 0.66 0.663
Margin Stability 0.95 0.96 0.96 0.97 0.98 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.98 0.98 0.99 0.99 0.99 0.99 0.986
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.83 0.83 0.50 0.50 0.50 0.95 0.86 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.00 0.44 0.65 0.46 0.01 0.00 0.00 0.88 0.70 0.42 0.14
ROE Trend -0.12 -0.17 -0.10 -0.14 -0.15 -0.05 -0.05 -0.02 -0.02 -0.02 -0.03 -0.04 -0.05 -0.05 -0.04 -0.09 -0.13 -0.15 -0.66 -0.69 -0.687
Gross Margin Trend 0.01 0.01 0.01 0.00 0.00 0.00 -0.00 0.00 0.01 0.01 0.02 0.01 0.00 0.00 0.01 0.02 0.02 0.02 0.01 0.00 0.001
FCF Margin Trend 0.01 0.01 0.04 0.03 -0.01 -0.00 -0.10 0.00 -0.02 -0.08 -0.12 -0.29 -0.20 -0.25 -0.18 -0.37 -0.39 -0.40 -0.50 -0.41 -0.409
Sustainable Growth Rate 7.5% 7.9% 6.9% 3.8% 2.3% 1.4% 1.2% 3.1% 2.9% 2.3% 0.5%
Internal Growth Rate 6.8% 7.2% 6.2% 3.3% 2.0% 1.2% 1.0% 2.7% 2.5% 2.0% 0.4%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.75 1.66 1.94 3.27 4.16 7.57 5.10 3.74 2.74 2.20 5.10 2.34 0.47 1.08 0.83 1.28 0.97 0.97 0.50 0.53 0.528
FCF/OCF 0.97 0.98 0.99 0.99 0.99 0.99 0.98 0.99 0.99 0.98 0.97 1.03 1.08 1.03 1.03 1.02 1.02 1.01 1.01 1.01 1.006
FCF/Net Income snapshot only 0.531
CapEx/Revenue 0.6% 0.5% 0.2% 0.2% 0.1% 0.2% 0.3% 0.3% 0.2% 0.2% 0.2% 0.2% 0.2% 0.3% 0.2% 0.5% 0.5% 0.5% 0.5% 0.4% 0.36%
CapEx/Depreciation snapshot only 0.058
Accruals Ratio -0.05 -0.04 -0.06 -0.07 -0.06 -0.08 -0.04 -0.07 -0.04 -0.02 -0.02 0.01 -0.01 0.00 -0.00 0.02 -0.00 -0.00 -0.19 -0.20 -0.197
Sloan Accruals snapshot only -0.262
Cash Flow Adequacy snapshot only -161.575
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.3% -0.4% -0.4% -0.3% -0.2% -0.2% -0.2% -0.2% -0.2% -0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return -0.3% -0.4% -0.4% -0.3% -0.2% -0.2% -0.2% -0.2% -0.2% -0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.77 0.77 0.78 0.74 0.71 0.63 0.56 0.65 0.64 0.67 0.40 1.27 0.91 0.91 0.82 0.80 0.79 0.79 1.59 1.60 1.600
Interest Burden (EBT/EBIT) 1.02 1.01 1.00 1.01 1.00 1.19 1.70 1.23 1.76 5.35 -0.61 0.15 0.37 0.48 0.56 0.88 0.96 0.99 1.00 0.96 0.955
EBIT Margin 0.16 0.17 0.16 0.09 0.06 0.03 0.03 0.08 0.06 0.02 -0.05 -0.14 -0.18 -0.20 -0.20 -0.32 -0.43 -0.51 -0.64 -0.72 -0.720
Asset Turnover 0.51 0.53 0.48 0.47 0.47 0.46 0.41 0.42 0.39 0.35 0.30 0.28 0.28 0.30 0.30 0.31 0.31 0.33 0.38 0.38 0.380
Equity Multiplier 1.18 1.18 1.18 1.18 1.18 1.18 1.19 1.19 1.19 1.19 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.32 1.32 1.323
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.57 $0.60 $0.58 $0.32 $0.19 $0.11 $0.11 $0.28 $0.26 $0.20 $0.04 $-0.08 $-0.19 $-0.28 $-0.32 $-0.76 $-1.13 $-1.43 $-3.73 $-4.03 $-4.03
Book Value/Share $7.97 $7.95 $8.82 $9.00 $8.89 $8.86 $9.22 $9.18 $9.16 $9.15 $9.47 $9.43 $9.36 $9.35 $9.24 $9.20 $9.13 $9.15 $5.54 $5.50 $4.72
Tangible Book/Share $7.59 $7.57 $8.47 $8.64 $8.53 $8.51 $8.89 $8.86 $8.84 $8.83 $7.36 $7.33 $7.27 $7.27 $7.28 $7.25 $7.19 $7.21 $3.56 $3.53 $3.53
Revenue/Share $4.54 $4.70 $4.69 $4.74 $4.62 $4.53 $4.45 $4.47 $4.14 $3.68 $3.35 $3.07 $3.13 $3.28 $3.41 $3.44 $3.45 $3.60 $3.66 $3.66 $3.66
FCF/Share $0.97 $0.97 $1.11 $1.04 $0.80 $0.85 $0.55 $1.03 $0.70 $0.44 $0.22 $-0.20 $-0.10 $-0.31 $-0.28 $-0.98 $-1.12 $-1.41 $-1.87 $-2.14 $-2.14
OCF/Share $1.00 $1.00 $1.12 $1.05 $0.80 $0.86 $0.56 $1.04 $0.71 $0.45 $0.22 $-0.20 $-0.09 $-0.30 $-0.27 $-0.96 $-1.10 $-1.39 $-1.85 $-2.13 $-2.13
Cash/Share $6.46 $6.45 $7.56 $7.71 $7.62 $7.60 $8.16 $8.13 $8.11 $8.11 $6.75 $6.72 $6.67 $6.66 $6.43 $6.40 $6.35 $6.36 $4.46 $4.44 $3.40
EBITDA/Share $0.78 $0.83 $0.79 $0.48 $0.32 $0.20 $0.16 $0.39 $0.27 $0.10 $-0.13 $-0.36 $-0.46 $-0.52 $-0.56 $-0.97 $-1.38 $-1.72 $-2.16 $-2.41 $-2.41
Debt/Share $0.24 $0.24 $0.22 $0.22 $0.22 $0.22 $0.19 $0.19 $0.19 $0.19 $0.16 $0.16 $0.16 $0.16 $0.21 $0.21 $0.21 $0.21 $0.21 $0.21 $0.21
Net Debt/Share $-6.22 $-6.21 $-7.35 $-7.49 $-7.40 $-7.38 $-7.97 $-7.94 $-7.92 $-7.91 $-6.59 $-6.56 $-6.51 $-6.50 $-6.21 $-6.19 $-6.14 $-6.15 $-4.25 $-4.23 $-4.23
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.277
Altman Z-Prime snapshot only 0.592
Piotroski F-Score 6 8 8 7 7 7 5 5 6 6 5 1 2 2 4 3 4 4 2 2 2
Beneish M-Score -2.55 -2.54 -2.67 -2.83 -2.74 -2.76 -2.64 -2.76 -2.56 -2.35 -2.03 -1.94 -2.15 -2.09 -2.28 -2.19 -2.26 -2.25 -3.65 -3.63 -3.635
Ohlson O-Score snapshot only -4.792
ROIC (Greenblatt) snapshot only -72.70%
Net-Net WC snapshot only $3.12
EVA snapshot only $-134283660.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 94.58 94.59 94.58 94.60 94.95 92.37 87.64 88.57 88.85 67.73 69.25 59.69 59.91 59.72 54.09 54.79 54.48 53.88 47.73 47.59 47.585
Credit Grade snapshot only 11
Credit Trend snapshot only -7.209
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 45
Sector Credit Rank snapshot only 40

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms